Mostrar el registro sencillo del ítem

dc.contributor.authorAgeitos Castiñeira, Lucía
dc.contributor.authorTorres, M.D.T.
dc.contributor.authorde la Fuente-Nunez, C.
dc.date.accessioned2025-08-26T11:01:47Z
dc.date.available2025-08-26T11:01:47Z
dc.date.issued2022
dc.identifier.citationAgeitos L, Torres MDT, de la Fuente-Nunez C. Biologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond. International Journal of Molecular Sciences. 2022;23(23).
dc.identifier.issn1422-0067
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/6416a45d5db420433b7b576a*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20810
dc.description.abstractPeptides are potential therapeutic alternatives against global diseases, such as antimicrobial-resistant infections and cancer. Venoms are a rich source of bioactive peptides that have evolved over time to act on specific targets of the prey. Peptides are one of the main components responsible for the biological activity and toxicity of venoms. South American organisms such as scorpions, snakes, and spiders are important producers of a myriad of peptides with different biological activities. In this review, we report the main venom-derived peptide families produced from South American organisms and their corresponding activities and biological targets.en
dc.description.sponsorshipNational Institute of General Medical Sciences of the National Institutes of Health (R35GM138201); Defense Threat Reduction Agency (DTRA; HDTRA11810041 and HDTRA1-21-1-0014).en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleBiologically Active Peptides from Venoms: Applications in Antibiotic Resistance, Cancer, and Beyond*
dc.typeReviewen
dc.authorsophosAgeitos, C. L.
dc.authorsophosTorres, M. D. T.
dc.authorsophosde la, Fuente-Nunez
dc.identifier.doi10.3390/ijms232315437
dc.identifier.sophos6416a45d5db420433b7b576a
dc.issue.number23
dc.journal.titleInternational Journal of Molecular Sciences*
dc.relation.projectIDNational Institute of General Medical Sciences of the National Institutes of Health [R35GM138201]; Defense Threat Reduction Agency (DTRA) [HDTRA11810041, HDTRA1-21-1-0014]
dc.relation.publisherversionhttps://www.mdpi.com/1422-0067/23/23/15437/pdf?version=1670333823;https://mdpi-res.com/d_attachment/ijms/ijms-23-15437/article_deploy/ijms-23-15437.pdf?version=1670333823es
dc.rights.accessRightsopenAccess
dc.subject.keywordINIBICes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo de Revisiónes
dc.volume.number23


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional